Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MRNA

What's Going On With Moderna Shares Today?

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 9.7% at $149.11 after the company reported better-than-expected fourth-quarter EPS and sales results and announced a new $3 billion buyback.

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Inc (NASDAQ:MRNA) reports a Q4 EPS of $11.29, a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9…

5 Stocks Trending on Reddit That are Worth Buying

5 Stocks Trending on Reddit That are Worth Buying

The retail trading boom led stocks like Gamestop (GME) to skyrocket last year, but the gains did not last. However, popular stocks on Reddit like Microsoft (MSFT), Moderna (MRNA), ON Semiconductor (ON), Chemours (CC), and MSC Industrial (MSM) could be poised for a run given their sound fundamentals and solid…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna Inc (NASDAQ: MRNA) has en

Check Out What Whales Are Doing With MRNA

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline

Moderna Inc (NASDAQ: MRNA) said it is deve

Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters

Moderna Inc's (NASDAQ: MRNA) CEO, Stephane Bancel, told Reuters that an

inkl

Read news from The Economist, FT, and more,
with one subscription

Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs

Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs

Spain's Laboratorios Farmaceuticos Rovi SA has agreed on a 10-year extension

Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Moderna Inc (NASDAQ: MRNA) shares are down more than 40% since the start of the year and continue to trend lower Monday.

Menstrual Irregularities Cases After mRNA COVID-19 Vaccine - EMA Reviews Cases

Menstrual Irregularities Cases After mRNA COVID-19 Vaccine - EMA Reviews Cases

The European Medicines Agency's safety committee is reviewing reports of heavy menstrual bleeding and absence of menstruation af

Moderna Whale Trades For February 02

Moderna Whale Trades For February 02

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 strange trades.

Why Moderna Shares Are Rising Today

Why Moderna Shares Are Rising Today

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

Moderna Whale Trades Spotted

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology

IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology

IAVI, the nonprofit scientific research organization, and Moderna Inc (NASDAQ: MRNA) have

Get all your
news in one place.

100's of premium titles.
One news app.

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically

Down Close to 40% Year-To-Date, Now is a Good Time to Scoop Up Moderna and BioNTech

The ongoing market correction has caused the shares of popular vaccine makers Moderna (MRNA) and BioNTech (BNTX) to decline nearly 40% in price so far this year. However, because the demand for COVID-19 vaccines remains strong globally, these companies are expected to generate substantial revenues and profits in the coming…

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Moderna Whale Trades For January 21

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Get all your
news in one place.

100's of premium titles.
One news app.

4 Growth Stocks to Buy on the Dip

Amid the current, inflationary environment, the Fed’s recent signal that it will raise interest rates aggressively precipitated a huge market sell-off last week. However, fundamentally sound growth stocks Anthem (ANTM), Zoetis (ZTS), Moderna (MRNA), and Forrester Research (FORR), which witnessed moderate corrections, could rebound soon. So, we think it could…

Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today

Shares of vaccine makers, including Moderna Inc (NASDAQ: MRNA), BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc.

Analyst Ratings For Moderna

Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter:

1 … 6 7 8 9

People

Stephane Bancel

Stéphane Bancel

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Board of Directors

European Medicines Agency

U.S. Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

392,116 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play